Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials (2020)
Source: Expert Opinion on Drug Metabolism & Toxicology. Unidade: FMRP
Subjects: CANABINOIDES, INTERAÇÃO DE DROGAS
ABNT
SANTOS, Rafael Guimarães dos et al. Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials. Expert Opinion on Drug Metabolism & Toxicology, v. 16, n. 6, p. 517-526, 2020Tradução . . Disponível em: https://doi.org/10.1080/17425255.2020.1754793. Acesso em: 18 out. 2024.APA
Santos, R. G. dos, Guimarães, F. S., Crippa, J. A. de S., Hallak, J. E. C., Rossi, G. N., Rocha, J. M., & Zuardi, A. W. (2020). Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials. Expert Opinion on Drug Metabolism & Toxicology, 16( 6), 517-526. doi:10.1080/17425255.2020.1754793NLM
Santos RG dos, Guimarães FS, Crippa JA de S, Hallak JEC, Rossi GN, Rocha JM, Zuardi AW. Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials [Internet]. Expert Opinion on Drug Metabolism & Toxicology. 2020 ; 16( 6): 517-526.[citado 2024 out. 18 ] Available from: https://doi.org/10.1080/17425255.2020.1754793Vancouver
Santos RG dos, Guimarães FS, Crippa JA de S, Hallak JEC, Rossi GN, Rocha JM, Zuardi AW. Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials [Internet]. Expert Opinion on Drug Metabolism & Toxicology. 2020 ; 16( 6): 517-526.[citado 2024 out. 18 ] Available from: https://doi.org/10.1080/17425255.2020.1754793